1. Home
  2. DWSN vs CNTB Comparison

DWSN vs CNTB Comparison

Compare DWSN & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

SELL

Current Price

$4.98

Market Cap

130.4M

Sector

Energy

ML Signal

SELL

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.14

Market Cap

135.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
CNTB
Founded
1952
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.4M
135.7M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
DWSN
CNTB
Price
$4.98
$2.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
312.9K
635.1K
Earning Date
05-12-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.25
N/A
Revenue
$145,773,000.00
$64,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.23
52 Week High
$7.85
$3.82

Technical Indicators

Market Signals
Indicator
DWSN
CNTB
Relative Strength Index (RSI) 48.80 44.00
Support Level $3.66 $2.10
Resistance Level $4.93 $2.75
Average True Range (ATR) 0.73 0.22
MACD -0.14 -0.02
Stochastic Oscillator 26.48 6.76

Price Performance

Historical Comparison
DWSN
CNTB

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: